BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 20871122)

  • 1. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care.
    Feary JR; Rodrigues LC; Smith CJ; Hubbard RB; Gibson JE
    Thorax; 2010 Nov; 65(11):956-62. PubMed ID: 20871122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart failure, myocardial infarction, lung cancer and death in COPD patients: a UK primary care study.
    Rodríguez LA; Wallander MA; Martín-Merino E; Johansson S
    Respir Med; 2010 Nov; 104(11):1691-9. PubMed ID: 20483577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidity complicates cardiovascular treatment: is diabetes the exception?
    Nouwens E; van Lieshout J; Wensing M
    Neth J Med; 2012 Sep; 70(7):298-305. PubMed ID: 22961822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program.
    Sidney S; Sorel M; Quesenberry CP; DeLuise C; Lanes S; Eisner MD
    Chest; 2005 Oct; 128(4):2068-75. PubMed ID: 16236856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease.
    Söderholm M; Inghammar M; Hedblad B; Egesten A; Engström G
    Eur J Epidemiol; 2016 Feb; 31(2):159-68. PubMed ID: 26711630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care.
    Soriano JB; Visick GT; Muellerova H; Payvandi N; Hansell AL
    Chest; 2005 Oct; 128(4):2099-107. PubMed ID: 16236861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic pain and pain medication use in chronic obstructive pulmonary disease. A cross-sectional study.
    Roberts MH; Mapel DW; Hartry A; Von Worley A; Thomson H
    Ann Am Thorac Soc; 2013 Aug; 10(4):290-8. PubMed ID: 23952846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients.
    Curkendall SM; DeLuise C; Jones JK; Lanes S; Stang MR; Goehring E; She D
    Ann Epidemiol; 2006 Jan; 16(1):63-70. PubMed ID: 16039877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial Infarction and Ischemic Stroke after Exacerbations of Chronic Obstructive Pulmonary Disease.
    Rothnie KJ; Connell O; Müllerová H; Smeeth L; Pearce N; Douglas I; Quint JK
    Ann Am Thorac Soc; 2018 Aug; 15(8):935-946. PubMed ID: 29723057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic obstructive pulmonary disease patients in the general practice].
    Siatkowska H; Kozielski J; Ziora D
    Pneumonol Alergol Pol; 2010; 78(2):112-20. PubMed ID: 20306422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young".
    Migliaresi P; Celentano A; Palmieri V; Pezzullo S; Martino S; Bonito M; Guillaro B; Brancati C; Di Minno G
    Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):468-72. PubMed ID: 17379491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals.
    Sode BF; Dahl M; Nordestgaard BG
    Eur Heart J; 2011 Oct; 32(19):2365-75. PubMed ID: 21875856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fasting blood glucose levels and blood pressure and treatment of diabetes and hypertension on the incidence of cardiovascular disease: a study of 740 patients with incident Type 2 diabetes with up to 30 years' follow-up.
    Jansson SP; Svärdsudd K; Andersson DK
    Diabet Med; 2014 Sep; 31(9):1055-63. PubMed ID: 24894815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity between chronic obstructive pulmonary disease and type 2 diabetes: A nation-wide cohort twin study.
    Meteran H; Backer V; Kyvik KO; Skytthe A; Thomsen SF
    Respir Med; 2015 Aug; 109(8):1026-30. PubMed ID: 26044811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.
    Nilsson PM; Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Fagard R; Gudbjörnsdóttir S;
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):506-12. PubMed ID: 19561510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of noncommunicable diseases by community health workers in Kerala: the epidemiology of noncommunicable diseases in rural areas (ENDIRA) study.
    Menon J; Joseph J; Thachil A; Attacheril TV; Banerjee A
    Glob Heart; 2014 Dec; 9(4):409-17. PubMed ID: 25592794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic obstructive pulmonary disease: a risk factor for type 2 diabetes: a nationwide population-based study.
    Lee CT; Mao IC; Lin CH; Lin SH; Hsieh MC
    Eur J Clin Invest; 2013 Nov; 43(11):1113-9. PubMed ID: 24028296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.
    Bengtsson C; Ohman ML; Nived O; Rantapää Dahlqvist S
    Lupus; 2012 Apr; 21(4):452-9. PubMed ID: 22065097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
    Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic obstructive pulmonary disease and comorbidities' influence on mortality in non-small cell lung cancer patients.
    Media AS; Persson M; Tajhizi N; Weinreich UM
    Acta Oncol; 2019 Aug; 58(8):1102-1106. PubMed ID: 31092081
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.